Streetbeat News

Products Services

MWG

Multi Ways Holdings Limited (NYSE:MWG), a leading supplier of heavy construction equipment in Singapore, announced its fleet expansion and renewal strategy, including a significant purchase agreement with SANY International Development Limited. This strategy aims to enhance its market position, service reliability, and cater to a wider customer base by integrating new and used equipment. The company's approach is driven by customer feedback and market analysis, focusing on reducing operational costs and adapting to changing needs. The construction demand forecast for 2024 in Singapore supports the timing of these investments.

Portfolio Pulse from Benzinga Newsdesk

February 20, 2024 | 1:38 pm

NVNO

enVVeno Medical announced it will present topline efficacy data from its VenoValve trial at the 2024 American Venous Forum Annual Meeting on March 6. This event is significant for investors as it could influence the company's stock performance based on the trial results.

Portfolio Pulse from Benzinga Newsdesk

February 20, 2024 | 1:37 pm

LCAA

LOT

Lotus Technology Inc. (Lotus Tech), a leading luxury electric vehicle maker, and L Catterton Asia Acquisition Corp (LCAA) announced the closing of their business combination, with Lotus Tech's ADS to start trading on Nasdaq under 'LOT' on February 23, 2024. The merger was approved by LCAA shareholders, and Lotus Tech aims to become a fully electric luxury mobility provider by 2027. The company has raised over $880 million in financing related to this transaction, marking a significant step in its growth and transition to electric vehicles.

Portfolio Pulse from Benzinga Newsdesk

February 20, 2024 | 1:36 pm

IOVA

WuXi Advanced Therapies (WuXi ATU), a subsidiary of WuXi AppTec, received FDA approval to manufacture AMTAGVI for Iovance Biotherapeutics (NASDAQ:IOVA), marking a significant milestone in the treatment of advanced melanoma. AMTAGVI, a one-time, individualized T cell therapy, is the first of its kind approved by the FDA for a solid tumor cancer. This approval positions WuXi ATU's Philadelphia site as the first U.S. external manufacturing and third-party contract testing organization for such therapy. Iovance, committed to developing TIL cell therapies, celebrates this as a step towards addressing unmet needs in advanced melanoma treatment.

Portfolio Pulse from Benzinga Newsdesk

February 20, 2024 | 1:35 pm

CHPT

ChargePoint Holdings, Inc. (NYSE:CHPT) shares are trading lower in the premarket session on Tuesday following the announcement of a collaborative agreement with AcBel Polytech, a subsidiary of Kinpo Group, to develop EV charging solutions. The partnership aims to accelerate product launches at reduced costs while maintaining quality, leveraging AcBel's power design expertise and Kinpo's manufacturing capabilities. ChargePoint's CEO, Rick Wilmer, highlighted the collaboration as a significant milestone for the company's product development strategy and operational excellence.

Portfolio Pulse from Nabaparna Bhattacharya

February 20, 2024 | 1:35 pm

SYNX

Silynxcom has received a purchase order for its SDR headset from a US-based military radio manufacturer, indicating a potential increase in revenue and strengthening its position in the defense sector.

Portfolio Pulse from Benzinga Newsdesk

February 20, 2024 | 1:34 pm

CAPR

Capricor Therapeutics is scaling up the production of CAP-1002 at a new facility in San Diego, with Cohort B of the HOPE-3 Phase 3 clinical trial expected to complete enrollment by Q2 2024.

Portfolio Pulse from Benzinga Newsdesk

February 20, 2024 | 1:34 pm

MLSS

Milestone Scientific has initiated direct sales of its STA Single Tooth Anesthesia System to a dental group in Maine, marking a significant step in its distribution strategy.

Portfolio Pulse from Benzinga Newsdesk

February 20, 2024 | 1:33 pm

TENX

Tenax Therapeutics has expanded its exclusive license agreement with Orion Corporation, extending its territory rights from North America to the entire world. This amendment allows Tenax to have global rights for the development and commercialization of certain products.

Portfolio Pulse from Benzinga Newsdesk

February 20, 2024 | 1:32 pm

MASI

Masimo (NASDAQ:MASI) and UCHealth have announced a strategic partnership to enhance patient care through telehealth and virtual care solutions. This collaboration aims to improve patient outcomes, reduce care costs, and transform care delivery models using Masimo's medical technology and UCHealth's clinical expertise. The partnership will focus on leveraging virtual care, remote monitoring, and advanced analytics to extend quality care beyond hospitals into homes.

Portfolio Pulse from Benzinga Newsdesk

February 20, 2024 | 1:31 pm